Relay Therapeutics earnings were -$337.7M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest RLAY earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$76.0M, down 13.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RLAY reported annual earnings of -$337.7M, with -1.2% growth. The next RLAY earnings date is Jun 3, 2025.
What were Relay Therapeutics's earnings last quarter?
On RLAY's earnings call on Invalid Date, Relay Therapeutics (NASDAQ: RLAY) reported Q4 2024 earnings per share (EPS) of -$0.42, up 37.31% year over year. Total RLAY earnings for the quarter were -$76.00 million. In the same quarter last year, Relay Therapeutics's earnings per share (EPS) was -$0.67.
The next RLAY earnings call is Invalid Date. Add RLAY to your watchlist to be reminded of Relay Therapeutics's next earnings date.
Is Relay Therapeutics profitable or losing money?
As of the last Relay Therapeutics earnings report, Relay Therapeutics is currently losing money. Relay Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$337.71 million, a 1.25% decrease year over year.
What was RLAY's earnings growth in the past year?
As of Relay Therapeutics's earnings date in Invalid Date, Relay Therapeutics's earnings has grown year over year. RLAY earnings in the past year totalled -$337.71 million.
What are Relay Therapeutics's earnings expectations?
The current EPS estimate for Relay Therapeutics's earnings report in Invalid Date is -$0.71.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.